Chemi-Luminescence ImmunoAssay (CLIA) for the determination of IgM antibodies to Herpes Simplex Virus type 1 and 2 in human plasma and sera. The device is intended for the follow-up of HSV infected patients and for the monitoring of risk of neonatal defects due to HSV infection during pregnancy. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative/qualitative determination of IgG antibodies to Herpes Simplex Virus type 1 and 2 in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the determination of IgM antibodies to Herpes Simplex Virus type 2 in human plasma and sera. The devise is intended for the follow-up of HSV infected patients and for the monitoring of risk of neonatal defects due to HSV infection during pregnancy. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative/qualitative determination of IgG antibodies to Herpes Simplex Virus type 2 in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the qualitative determination of IgM antibodies to Herpes Simplex Virus type 1 in human plasma and sera. The devise is intended for the follow-up of HSV infected patients and for the monitoring of risk of neonatal defects due to HSV infection during pregnancy. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative/qualitative determination of IgG antibodies to Herpes Simplex Virus type 1 in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Immunocapture based Chemi-Luminescence Immuno-Assay (CLIA) for the determination of IgM antibodies specific to Cytomegalovirus in human plasma and sera from patients undergoing an acute CMV infection, virus reactivation and from women in pregnancy monitoring. The device has been adapted for the use in exclusive combination with the Dia.Pro’s instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative determination of IgG antibodies to Cytomegalovirus in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Immunocapture based ChemiLuminescence ImmunoAssay (CLIA) for the determination of IgM antibodies to Rubella virus in human plasma and sera from patients undergoing an acute infection and from women in pregnancy monitoring. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative determination of IgG antibodies to Rubella Virus in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Immunocapture based ChemiLuminescence ImmunoAssay (CLIA) for the determination of IgM antibodies to Toxoplasma in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative determination of IgG antibodies to Toxoplasma in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.